Article

OPIOIDIQ: Experience a documentary series on opioid use

Brought to you by Collegium Pharmaceutical, Inc.: OpioidIQ offers downloadable tools to help you identify unintentional opioid misuse, enhance patient communication, and optimize treatment management.

OpioidIQ offers a 5-chapter documentary series on the following topics:

  • Chapter 1. Appropriate opioid use: guidelines, tools, and patient management Weighing the benefits and risks of opioid treatment can help ensure appropriate use
  • Chapter 2. The dangers of unintentional opioid misuse Unintentional opioid misuse: a problem that’s often overlooked
  • Chapter 3. Taking action to enhance communication Communication plays an important role in avoiding unintentional misuse
  • Chapter 4. Empowering patients & caregivers Empower patients and caregivers to avoid unintentional misuse
  • Chapter 5. Addressing misuse with ADF technology Abuse-deterrent formulations (ADFs) help address unintentional misuse

To watch this documentary series on safe and proper opioid use, visit OpioidIQ.com

Who we are

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company developing and commercializing products for the treatment of patients suffering from chronic pain and other diseases

Our mission

To provide innovative medications through scientific technology

Our vision

We believe that patients who need treatment shouldn’t go undertreated. That’s why we’re using cutting-edge technology to make important medications available in novel formulations. Our vision is to responsibly deliver safe and effective solutions to underserved patients, healthcare providers, and society.

780 Dedham Street, Suite 800

Canton, MA 02021

©2016 Collegium Pharmaceutical, Inc. All rights reserved.

Related Videos
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Jörn Schattenberg, MD | Credit: Novo Nordisk
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.